FIS
FCPM III Services Portfolio holdings
AUM
$500M
1-Year Est. Return
11.2%
1 Year Est. Return
+11.2%
AUM
$369M
AUM Growth
-$44.6M
(-11%)
Holding
8
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NewAmsterdam Pharma
NAMS
$4.35B
| $193M | 52.16% |
10,632,113
-303,197
|
|
||
2
Dyne Therapeutics
DYN
$2.68B
| $52M | 14.09% |
5,462,846
|
|
||
3
Replimune Group
REPL
$705M
| $36.3M | 9.84% |
3,909,696
|
|
||
4
enGene Holdings
ENGN
$437M
| $35.1M | 9.5% |
9,632,561
|
|
||
|
BCYC
5
Bicycle Therapeutics
BCYC
$450M
| $24M | 6.5% |
3,452,330
|
|
||
6
Astria Therapeutics
ATXS
$718M
| $23.4M | 6.34% |
4,107,537
+285,000
|
|
||
7
RAPT Therapeutics
RAPT
$799M
| $3.45M | 0.93% |
+440,176
|
|
||
|
8
enGene Holdings Warrants
ENGNW
$28.2M
| $2.36M | 0.64% |
2,878,148
|
|